Literature DB >> 30423153

New TNM classification (AJCC eighth edition) of bone and soft tissue sarcomas: JCOG Bone and Soft Tissue Tumor Study Group.

Kazuhiro Tanaka1, Toshifumi Ozaki2.   

Abstract

The Cancer Staging Manual of the American Joint Committee on Cancer (AJCC) has recently been revised and updated to its eighth edition. This review focuses on the new staging system of bone and soft tissue sarcomas and outlines the revision points and caveats in the latest edition. The major changes in the eighth edition of the AJCC staging for bone and soft tissue sarcomas are the following four points. (i) Tumors are described separately according to the primary sites. For bone sarcoma, three tumor locations are described: (a) appendicular skeleton, trunk, skull and facial bones; (b) spine and (c) pelvis. Meanwhile, four tumor locations are described for soft tissue sarcoma: (1) trunk and extremity; (2) retroperitoneum; (3) head and neck and (4) visceral sites. (ii) Histologic grading system in bone sarcoma is changed to three-grade classifications. (iii) For soft tissue sarcoma, AnyTN1M0 tumor in the trunk and extremity is classified as stage IV, whereas for the retroperitoneal tumor, anyTN1M0 remains as stage IIIB. (iv) For soft tissue sarcomas in the trunk, extremity and retroperitoneum, tumor size was classified into four categories: (a) ≤5 cm; (b) >5 cm and ≤10 cm; (c) >10 cm and ≤15 cm and (d) >15 cm. In addition, the notation about the depth of the tumor (superficial or deep from the superficial fascia) has been eliminated.

Entities:  

Mesh:

Year:  2019        PMID: 30423153     DOI: 10.1093/jjco/hyy157

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN: 0368-2811            Impact factor:   3.019


  25 in total

Review 1.  Diagnosis and Management of Subcutaneous Soft Tissue Sarcoma.

Authors:  Makoto Endo; Nokitaka Setsu; Toshifumi Fujiwara; Takeaki Ishii; Makoto Nakagawa; Kenichiro Yahiro; Atsushi Kimura; Eijiro Shimada; Yasuharu Nakashima; Yoshihiro Matsumoto
Journal:  Curr Treat Options Oncol       Date:  2019-05-25

Review 2.  Magnetic resonance imaging of soft tissue sarcoma: features related to prognosis.

Authors:  Giulia Scalas; Anna Parmeggiani; Claudia Martella; Gianmarco Tuzzato; Giuseppe Bianchi; Giancarlo Facchini; Roberta Clinca; Paolo Spinnato
Journal:  Eur J Orthop Surg Traumatol       Date:  2021-05-29

3.  Outcomes of Sarcopenia Treatment for Malignant Bone and Soft Tissue Tumors in Elderly Patients.

Authors:  Yoshitaka Ban; Hoshi Manabu; Naoto Oebisu; Akiyoshi Shimatani; Naoki Takada; Hiroaki Nakamura
Journal:  Cancer Diagn Progn       Date:  2022-03-03

4.  Outcomes and computed tomography radiomic features extraction in soft tissue sarcomas treated with neoadjuvant radiation therapy.

Authors:  Javier González-Viguera; Gabriel Reynés-Llompart; Alicia Lozano
Journal:  Rep Pract Oncol Radiother       Date:  2021-09-30

5.  The early-stage of primary pulmonary synovial sarcoma: A case report.

Authors:  Diana Rahmaniar; Daniel Maranatha
Journal:  Int J Surg Case Rep       Date:  2022-05-24

6.  A review of staging chest CT in trunk and extremity soft tissue sarcoma.

Authors:  Asif Saifuddin; Hassan Shafiq; Ramanan Rajakulasingam; Alan Tan; Paul O'Donnell; Michael Khoo
Journal:  Br J Radiol       Date:  2020-11-26       Impact factor: 3.039

7.  Soft-tissue reconstruction after soft-tissue sarcoma resection: the clinical outcomes of 24 patients.

Authors:  Hideo Hasegawa; Shinji Tsukamoto; Kanya Honoki; Takamasa Shimizu; Lorenzo Ferra; Costantino Errani; Spyros Sioutis; Andreas F Mavrogenis; Yasuhito Tanaka
Journal:  Eur J Orthop Surg Traumatol       Date:  2021-02-20

8.  Identifying Modifiable and Non-modifiable Risk Factors of Readmission and Short-Term Mortality in Chondrosarcoma: A National Cancer Database Study.

Authors:  Daniel R Evans; Alexander L Lazarides; Mark M Cullen; Jason A Somarelli; Dan G Blazer; Julia D Visguass; Brian E Brigman; William C Eward
Journal:  Ann Surg Oncol       Date:  2021-09-27       Impact factor: 5.344

9.  MCM4 Is a Novel Biomarker Associated With Genomic Instability, BRCAness Phenotype, and Therapeutic Potentials in Soft-Tissue Sarcoma.

Authors:  Qi Liu; Qiyuan Bao; Yiqi Xu; Yucheng Fu; Zhijian Jin; Jun Wang; Weibin Zhang; Yuhui Shen
Journal:  Front Cell Dev Biol       Date:  2021-06-10

10.  Prognostic implications of PD-L1 expression in patients with angiosarcoma.

Authors:  Jii Bum Lee; Beung-Chul Ahn; Seung Hyun Kim; Young Han Lee; Jung Woo Han; Min Kyung Jeon; Soo Hee Kim; Hyo Song Kim
Journal:  Future Sci OA       Date:  2021-03-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.